NCT05296707

Brief Summary

As inflammation and oxidative stress increase in asthma patients, the severity of symptoms and clinical findings increase. Therefore, this study was planned to evaluate the possible effect of inspiratory muscle training (IMT) on inflammation markers and oxidative stress in childhood asthma. The study included asthma patient; 35 routine medication, 35 drug therapy and inspiratory muscle training (IMT), and 35 healthy total 105 children aged 8-17 years. Demographic information and hemogram values were recorded. Functional capacity was evaluated with the 6-minute walking test, quality of life PedsQL, respiratory muscle strength oral pressure measuring device, respiratory function test, dyspnea severity with Modified Borg Scale. C-Reactive Protein (CRP), Periostin, Transforming Growth Factor-βeta (TGF-β), Total Antioxidant Status (TAS), Total Oxidant Status (TOS), Oxidative Stress Index (OSI) were analyzed. IMT was given with a Threshold IMT device for 7 days/6 weeks at 30% of maximal inspiratory pressure, and then a second evaluation was made.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

March 3, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 25, 2022

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

1.3 years

First QC Date

March 3, 2022

Last Update Submit

February 15, 2024

Conditions

Keywords

Childhood AsthmaInspiratory Muscle TrainingInflammation

Outcome Measures

Primary Outcomes (6)

  • Inflammatory marker

    We assessed C reaktive protein from Blood sample

    6 weeks

  • Inflammatory marker

    We assessed TGF-B from Blood sample

    6 weeks

  • Inflammatory marker

    We assessed Periostin from Blood sample

    6 weeks

  • Oxidative stress

    We assessed Total oxidative level.

    6 weeks

  • Oxidative stress

    We assessed total antioxidative level

    6 weeks

  • Oxidative stress

    We assessed oxidative status index

    6 weeks

Secondary Outcomes (4)

  • Pulmonary function test

    6 weeks

  • Respiratory muscle strength

    6 weeks

  • functional capacity

    6 weeks

  • Quality life

    6 weeks

Study Arms (3)

Inspiratory muscle training group

EXPERIMENTAL

Threshold IMT was given this group. Applied for 7 days 6 weeks.

Other: Inspiratory muscle trainingOther: Used routine medicine

Used routine medicine group

ACTIVE COMPARATOR

Followed 6 weeks

Other: Used routine medicine

Control Group

ACTIVE COMPARATOR

Health children

Other: Control group

Interventions

The MIP/MEP value of the group that will receive inspiratory muscle training was determined and Threshold IMT training was given with 30%. In the training, the subjects were asked to sit in a relaxed position with their upper chest and shoulders relaxed. After the nose clip was attached, the children were asked to inhale and exhale by tightly closing the mouthpiece of the instrument with their lips. A 30-minute training session was carried out for 6 weeks, with 10-15 repetitive breathing apparatus and 5-10 seconds rest breaks every day.

Inspiratory muscle training group

After the first evaluation was made, a second evaluation was made after 6 weeks of follow-up.

Inspiratory muscle training groupUsed routine medicine group

A healthy child compatible with the age and sex of the patient group was evaluated once.

Control Group

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Have been diagnosed with asthma,
  • Between the ages of 8-17,
  • No asthma attack,
  • Cooperating with the study,
  • Without cerebral palsy, mental retardation or any other major neurological diagnosis,
  • Agreeing to participate in the study,
  • Cases whose medication has not been changed for at least three weeks.

You may not qualify if:

  • Presence of kyphoscoliosis that may affect respiration,
  • Having advanced postural alignment problem,
  • Having mental problems,
  • Having neuromuscular disease,
  • Making changes in the medications used in the last three weeks,
  • Presence of inflammatory diseases such as juvenile idiopathic arthritis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University

Izmir, Karsıyaka, Turkey (Türkiye)

Location

Related Publications (1)

  • Gokcek O, Yurdalan U, Tugay BU, El C, Dogan S. Evaluation of the possible effect of inspiratory muscle training on inflammation markers and oxidative stress in childhood asthma. Eur J Pediatr. 2023 Aug;182(8):3713-3722. doi: 10.1007/s00431-023-05047-4. Epub 2023 Jun 7.

MeSH Terms

Conditions

Inflammation

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 3, 2022

First Posted

March 25, 2022

Study Start

March 1, 2019

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations